Why is Laurus Labs falling/rising?

As of 26-Sep, Laurus Labs Ltd is experiencing a decline in its stock price, currently at Rs 832.70, which reflects a decrease of Rs 63.2 or 7.05%. The stock has underperformed the sector by 4.71% today and has been on a downward trend for the last three days, accumulating a total loss of 8.49% during this period. The stock touched an intraday low of Rs 822.85, indicating significant selling pressure. Despite a strong year-to-date performance of 38.24% and a remarkable 79.77% increase over the past year, the recent performance has been overshadowed by a 10.63% decline over the past week and a 3.82% drop in the last month. The company's high management efficiency and strong growth in net profit, along with positive results over the last three quarters, suggest underlying strength; however, the stock's recent performance is being negatively impacted by falling investor participation and a decline in the pharmaceuticals sector.
Broader market context shows that while Laurus Labs has outperformed the benchmark Sensex over the long term, its recent short-term performance has been less favorable compared to the index, which has only declined by 2.66% over the past week. The stock's liquidity remains adequate for trading, but the significant drop in delivery volume indicates waning investor interest. Additionally, concerns regarding poor long-term growth and an expensive valuation relative to its peers may be contributing to the stock's current downward trajectory. Overall, while Laurus Labs has demonstrated strong historical performance, recent trends and market conditions are leading to its current decline.